The Clinical Features of Gout
Gout is caused by the crystal deposition of monosodium urate in and around joint tissues. The first joint affected in the majority of cases is the first metatarsophalangeal joint, a condition known as podagra. Acute gout is characterized by the rapid development of warmth, swelling, erythema, and pain in the affected joint. The natural history of gout is to worsen with time, progressing through the stages of asymptomatic hyperuri-cemia and acute intermittent gouty attacks to tophaceous gout. The time period between the first development of acute intermittent gouty attacks and the appearance of chronic tophaceous gout is approximately a decade in most cases. The development of tophaceous deposits of monosodium urate is a function of the degree and duration of hyperuricemia. However, most people with hyperuricemia never develop clinical gout.
KeywordsUric Acid Synovial Fluid Familial Mediterranean Fever Serum Uric Acid Level Acute Gout
- Centers for Disease Control and Prevention, national Center for Health Statistics. Vital and health statistics: current estimates from the national Health Interview Survey, 1996. Series 10, No. 200. Atlanta: Department of Health and Human Services (US). Available at http://www.cdc.gov/nchs/data/series/sr_10/sr10_200.pdf
- Famaey JP. Colchicine in therapy. State of the art and new perspectives for an old drug. Clin Exp Rheum. 1988;6(3):305–17Google Scholar
- Hippocrates. The genuine works of Hippocrates, volumes 1 and 2. Translated and edited by Adams F. New York: Wood; 1886Google Scholar
- Molad Y, Cronstein BN, Malawista SE. Colchicine. In: Smyth CJ, Holers VM, editors. Gout, hyperuricemia, and other crystal-associated arthropathies. New York: Marcel Dekker; 1998. p. 193–204Google Scholar